Lower-Sensitivity and Avidity Modifications of the Vitros Anti-HIV 1+2 Assay for Detection of Recent HIV Infections and Incidence Estimation

Recent-infection testing assays/algorithms (RITAs) have been developed to exploit the titer and avidity of HIV antibody evolution following seroconversion for incidence estimation. The Vitros Anti-HIV 1+2 assay (Ortho-Clinical Diagnostics) was approved by the FDA to detect HIV-1 and HIV-2 infections...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Keating, Sheila M., Hanson, Debra, Lebedeva, Mila, Laeyendecker, Oliver, Ali-Napo, N′ko L., Owen, S. Michele, Stramer, Susan L., Moore, Richard D., Norris, Philip J., Busch, Michael P.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Virology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3503010/
https://ncbi.nlm.nih.gov/pubmed/23035182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.01454-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares